Psychosomatic Medicine
Q2IF2.8SJR0.918
US
USJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.8 | Q2 | 66.0% | 0.918 | Q2 | 81.6% |
| 2024 | 2.4 | Q2 | 72.4% | 0.998 | Q2 | 84.2% |
| 2023 | 2.9 | Q1 | 78.9% | 1.081 | Q1 | 87.3% |
| 2022 | 3.3 | Q2 | 77.3% | 1.105 | Q1 | 88.4% |
| 2021 | 3.9 | Q2 | 80.2% | 1.130 | Q1 | 89.0% |
| 2020 | — | — | 1.620 | Q1 | 93.4% | |
| 2019 | — | — | 1.731 | Q1 | 94.3% | |
| 2018 | — | — | 1.962 | Q1 | 94.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1534-7796
ISSN
0033-3174
country
UScoverage
1945-2025